(2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside(CAS: 13241-32-2)

The compound (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside (CAS: 13241-32-2) is subject to various regulatory guidelines including GHS classification, REACH regulations, and FDA/EPA requirements for safety, handling, and environmental considerations. GHS classification focuses on hazard communication, while REACH regulation in the EU covers registration, evaluation, authorization, and restriction of chemicals. FDA and EPA guidelines are specific to the safe handling, storage, and disposal of the compound in the United States.

In the synthesis of (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside (CAS: 13241-32-2), alternatives such as analogous compounds and isomers can be explored. Common alternative reagents include different sugars or phenolic compounds, which can serve as starting materials or intermediates in the synthesis. These alternatives can provide similar functional groups and structural features, making them viable substitutes in various synthetic routes.

The market and research trends for (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside (CAS: 13241-32-2) are predominantly focused on its potential applications in medicinal chemistry and natural product research. There is growing interest in exploring its bioactivity and pharmacological properties, which may lead to its use as a therapeutic agent or as a model compound for further research. The compound's complex structure and unique functional groups make it a valuable target for structural biology and drug discovery.

Waste containing (2S)-2-(3,4-Dihydroxyphenyl)-5-hydroxy-4-oxo-3,4-dihydro-2H-chromen-7-yl 2-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside (CAS: 13241-32-2) should be managed according to strict environmental protection regulations. Collection of waste in dedicated containers followed by incineration or professional waste disposal services is recommended. Proper labeling and documentation are essential to ensure compliance with local and international environmental standards. Additionally, precautionary measures should be taken to prevent exposure to personnel and to minimize environmental impact during handling and disposal.